Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. A higher prevalence of psychiatric comorbidities, including depressive disorder, anxiety disorder, and bipolar disorder has been proved in patients with PCOS. However, a clear temporal causal relationship between PCOS and psychiatric disorders has not been well established. OBJECTIVE: We explored the relationship between PCOS and the subsequent development of psychiatric disorders including schizophrenia, bipolar disorder, depressive disorder, anxiety disorder, and sleep disorder. METHODS: We identified patients who were diagnosed with PCOS by an obstetrician-gynecologist in the Taiwan National Health Insurance Research Database. A comparison cohort was constructed of patients without PCOS who were matched according to age and sex. The occurrence of subsequent new-onset psychiatric disorders was evaluated in both cohorts based on diagnoses made by psychiatrists. RESULTS: The PCOS cohort consisted of 5431 patients, and the comparison cohort consisted of 21,724 matched control patients without PCOS. The incidence of depressive disorder (hazard ratio [HR] 1.296, 95% confidence interval [CI] 1.084-.550), anxiety disorder (HR 1.392, 95% CI 1.121-1.729), and sleep disorder (HR 1.495, 95% CI 1.176-1.899) were higher among the PCOS patients than among the patients in the comparison cohort. In addition, a higher incidence of newly diagnosed depressive disorder, anxiety disorder, and sleep disorder remained significantly increased in all of the stratified follow-up durations (0-1, 1-5, ≥5 y). CONCLUSIONS: PCOS might increase the risk of subsequent newly diagnosed depressive disorder, anxiety disorder, and sleep disorder. The risk of newly diagnosed bipolar disorder, which has often been reported in the literature to be comorbid with PCOS, was not significantly elevated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies however, reported higher prevalence of OSA irrespective of BMI in PCOS, raising the possibility that body fat distribution rather than total body mass may be more useful in determining OSAS risk in PCOS or that other factors may contribute to this association (8, 27, 28).”
From Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (2025) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“PCOS is a complex illness that is characterized by irregular menses, excessive amounts of androgenic hormones, and polycystic ovaries [2].”
BackgroundProfound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Association between obesity and psychiatric disorders in the US adult population
Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.824 · Cited by 1,338 · cited 1×
“Second, insulin resistance [26] and obesity [27–29], which are common symptoms in patients with PCOS, have been noted to be related to depressive symptoms.”
BackgroundEpidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302 · cited 1×
“Insulin resistance affects 50%–70% [30] of women with PCOS and the effect of obesity on insulin resistance is additive to that of PCOS [3].”
BackgroundWu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818 · cited 1×
“Instituted in 1995, the National Health Insurance (NHI) program is a mandatory health insurance program that offers comprehensive medical care coverage, including outpatient, inpatient, emergency, and traditional Chinese medicine, to all residents of Taiwan, with a coverage rate of up to 98% [15].”
BackgroundFranks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Prospective association between obesity and depression: evidence from the Alameda County Study
Roberts, R. E., Deleger, S., Strawbridge, W. J., & Kaplan, G. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802204 · Cited by 673 · cited 1×
“Second, insulin resistance [26] and obesity [27–29], which are common symptoms in patients with PCOS, have been noted to be related to depressive symptoms.”
BackgroundIncreased risk of depressive disorders in women with polycystic ovary syndrome
Hollinrake, E., Abreu, A., Maifeld, M., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.039 · Cited by 631
MALLON, NEWTON, KLASSEN, STEWART-BROWN, RYAN, & FINLAY (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02768.x · Cited by 514 · cited 1×
“Certain studies have reported that hirsutism [19] and acne [20] are associated with anxiety, whereas another study did not observe this association [21].”
BackgroundLipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477 · cited 1×
“Studies have demonstrated insulin resistance in women with PCOS might lead to a number of comorbidities including hypertension [4], type 2 diabetes [31] and dyslipidemia [32,33].”
BackgroundChanges in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study
Legro, R. S., Gnatuk, C. L., Kunselman, A. R., & Dunaif, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1843 · Cited by 306 · cited 1×
“Studies have demonstrated insulin resistance in women with PCOS might lead to a number of comorbidities including hypertension [4], type 2 diabetes [31] and dyslipidemia [32,33].”
BackgroundAnderson, S. E., Cohen, P., Naumova, E. N., Jacques, P. F., & Must, A. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815580b4 · Cited by 306
Surveillance Bias in Outcomes Reporting
Haut, E. R. (2011) · JAMA · doi:10.1001/jama.2011.822 · Cited by 262
Women with polycystic ovary syndrome are often depressed or anxious—A case control study
Månsson, M., Holte, J., Landin-Wilhelmsen, K., Dahlgren, E., Johansson, A., & Landén, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.003 · Cited by 260 · cited 1×
“Several studies have confirmed that depression and anxiety are the most common comorbidities in patients with PCOS [6,17,18].”
BackgroundPolycystic Ovary Syndrome and Mental Health: A Review
Himelein, M. J., & Thatcher, S. S. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000243772.33357.84 · Cited by 239 · cited 1×
“Hirsutism and acne resulting from hyperandrogenism in patients with PCOS are strongly associated with a person’ dissatisfaction with their body and depression [22], indicating a link between hyperandrogenism and depression among women with PCOS.”
BackgroundKerchner, A., Lester, W., Stuart, S. P., & Dokras, A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.022 · Cited by 232 · cited 1×
“Certain studies have reported that hirsutism [19] and acne [20] are associated with anxiety, whereas another study did not observe this association [21].”
BackgroundWeiner, C. L., Primeau, M., & Ehrmann, D. A. (2004) · Psychosomatic Medicine · doi:10.1097/00006842-200405000-00011 · Cited by 231 · cited 1×
“However, no consistent evidence has been provided supporting the finding that hyperandrogenism directly increases the risk of developing depressive disorder [23–25].”
BackgroundPsychological interactions with infertility among women
Cwikel, J., Gidron, Y., & Sheiner, E. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.05.004 · Cited by 224 · cited 1×
“Lastly, studies have indicated that depressive disorders among PCOS patients might be caused by psychological stresses associated with reduced fertility or assisted reproductive treatment [34].”
BackgroundDepression in women with polycystic ovary syndrome: clinical and biochemical correlates
Rasgon, N. L., Rao, R. C., Hwang, S., Altshuler, L. L., Elman, S., Zuckerbrow-Miller, J., & Korenman, S. G. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00117-9 · Cited by 210 · cited 1×
“First, higher serum levels of androgens have been implicated in the incidence of psychological disturbances among PCOS patients [8].”
BackgroundQuality of life of hirsute women
Sonino, N., Fava, G. A., Mani, E., Belluardo, P., & Boscaro, M. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.809.186 · Cited by 193 · cited 1×
“Certain studies have reported that hirsutism [19] and acne [20] are associated with anxiety, whereas another study did not observe this association [21].”
BackgroundDepression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011) · Human Reproduction · doi:10.1093/humrep/der338 · Cited by 168 · cited 1×
“Several studies have confirmed that depression and anxiety are the most common comorbidities in patients with PCOS [6,17,18].”
BackgroundPrevalence of psychiatric disorders in patients with polycystic ovary syndrome
Rassi, A., Veras, A. B., dos Reis, M., Pastore, D. L., Bruno, L. M., Bruno, R. V., de Ávila, M. A. P., & Nardi, A. E. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.02.009 · Cited by 117 · cited 1×
“Several studies have confirmed that depression and anxiety are the most common comorbidities in patients with PCOS [6,17,18].”
BackgroundSoares, C. N. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0100-1 · Cited by 107 · cited 1×
“Evidence has shown that hormonal change, which is a typical clinical presentation of PCOS, can increase the susceptibility of women to psychiatric conditions [12–14].”
BackgroundPolycystic ovary syndrome in women using valproate: A review
Bilo, L., & Meo, R. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802288259 · Cited by 106 · cited 1×
“The increased prevalence of PCOS associated with valproic acid prescription was observed in both women with epilepsy and women with bipolar disorders [36].”
BackgroundSex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF
Wu, Y. C., Hill, R., Gogos, A., & van den Buuse, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.024 · Cited by 100 · cited 1×
“Evidence has shown that hormonal change, which is a typical clinical presentation of PCOS, can increase the susceptibility of women to psychiatric conditions [12–14].”
BackgroundAçmaz, G., Albayrak, E., Acmaz, B., Başer, M., Soyak, M., Zararsız, G., & İpekMüderris, İ. (2013) · The Scientific World Journal · doi:10.1155/2013/851815 · Cited by 88 · cited 1×
“Furthermore, a study reported that these comorbid psychiatric problems affect the quality of life of PCOS patients [11].”
BackgroundPsychological investigation in patients with polycystic ovary syndrome
Bazarganipour, F., Ziaei, S., Montazeri, A., Foroozanfard, F., Kazemnejad, A., & Faghihzadeh, S. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-141 · Cited by 88 · cited 2×
“9% of women with PCOS have at least one psychiatric disorder [5–7], and higher incidences of psychiatric disorders have been observed in women with PCOS, particularly depressive disorder, bipolar disorder, and anxiety disorder [8–10].”
BackgroundOvarian Hypertension: Polycystic Ovary Syndrome
Bentley-Lewis, R., Seely, E., & Dunaif, A. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.009 · Cited by 78 · cited 2×
“Recently, it has been postulated that PCOS is linked to an increased risk for cardiovascular diseases [3] and type 2 diabetes [4] in affected women.”
BackgroundPan, A., Ye, X., Franco, O. H., Li, H., Yu, Z., Zou, S., Zhang, Z., Jiao, S., & Xu, L. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.11.002 · Cited by 76 · cited 1×
“Second, insulin resistance [26] and obesity [27–29], which are common symptoms in patients with PCOS, have been noted to be related to depressive symptoms.”
BackgroundPoor sleep in PCOS; is melatonin the culprit?
Shreeve, N., Cagampang, F., Sadek, K., Tolhurst, M., Houldey, A., Hill, C. M., Brook, N., Macklon, N., & Cheong, Y. (2013) · Human Reproduction · doi:10.1093/humrep/det013 · Cited by 73 · cited 1×
“Second, regardless of OSA, studies have shown that the sleep disorders in patients with PCOS might be related to raised nighttime urinary melatonin levels, which are associated with lower sleep quality [39].”
BackgroundSleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome
Nandalike, K., Agarwal, C., Strauss, T., Coupey, S. M., Isasi, C. R., Sin, S., & Arens, R. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.07.002 · Cited by 68 · cited 1×
“First, the prevalence of obstructive sleep apnea (OSA) was higher in PCOS patients [37], and the mechanisms might be associated with the obesity caused by PCOS-induced metabolic abnormalities [38].”
BackgroundLegro, R. S., Blanche, P. J., Krauss, R. M., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00401-x · Cited by 66 · cited 1×
“Studies have demonstrated insulin resistance in women with PCOS might lead to a number of comorbidities including hypertension [4], type 2 diabetes [31] and dyslipidemia [32,33].”
BackgroundCirillo, P. C., Passos, R. B. F., Bevilaqua, M. C. D. N., López, J. R. R. A., & Nardi, A. E. (2012) · Revista Brasileira de Psiquiatria · doi:10.1016/j.rbp.2012.04.010 · Cited by 55 · cited 1×
“Evidence has shown that hormonal change, which is a typical clinical presentation of PCOS, can increase the susceptibility of women to psychiatric conditions [12–14].”
BackgroundAnnagür, B. B., Tazegül, A., Uğuz, F., Kerimoğlu, Ö. S., Tekinarslan, E., & Çelık, Ç. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.002 · Cited by 54 · cited 1×
“However, no consistent evidence has been provided supporting the finding that hyperandrogenism directly increases the risk of developing depressive disorder [23–25].”
BackgroundScreening for bipolar disorder in women with polycystic ovary syndrome: A pilot study
Klipstein, K. G., & Goldberg, J. F. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.011 · Cited by 51 · cited 3×
“9% of women with PCOS have at least one psychiatric disorder [5–7], and higher incidences of psychiatric disorders have been observed in women with PCOS, particularly depressive disorder, bipolar disorder, and anxiety disorder [8–10].”
BackgroundAxis I and Axis II diagnoses in women with PCOS
Şahingöz, M., Uğuz, F., Gezginç, K., & Korucu, D. G. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.04.003 · Cited by 32 · cited 1×
“Evidence has shown that schizophrenia is not more highly prevalent among the PCOS patients than patients without PCOS [5,35].”
Backgroundde Sousa, G., Schlüter, B., Buschatz, D., Menke, T., Trowitzsch, E., Andler, W., & Reinehr, T. (2011) · Sleep And Breathing · doi:10.1007/s11325-010-0469-6 · Cited by 22
Testosterone and dehydroepiandrosterone sulfate in female anxious and non-anxious major depression
Oulis, P., Masdrakis, V. G., & Markianos, M. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.845222 · Cited by 17 · cited 1×
“However, no consistent evidence has been provided supporting the finding that hyperandrogenism directly increases the risk of developing depressive disorder [23–25].”
Background[Polycystic ovarian syndrome and obstructive sleep apnea].
Gateva, A., Kamenov, Z. A., Mondeshki, T., Bilyukov, R., & Georgiev, O. (2013) · PubMed · Cited by 5
Cited by
Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A. (2017) · Human Reproduction · doi:10.1093/humrep/dex044 · Cited by 631
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Dokras, A., Stener-Victorin, E., Yildiz, B. O., Li, R., Ottey, S., Shah, D., Epperson, N., & Teede, H. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.038 · Cited by 285
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Abraham Gnanadass, S., Divakar Prabhu, Y., & Valsala Gopalakrishnan, A. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 272
Beyond fertility: polycystic ovary syndrome and long-term health
Cooney, L. G., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.021 · Cited by 270
Metadata
- Authors
- Hung, J.-H., Hu, L.-Y., Tsai, S.-J., Yang, A. C., Huang, M.-W., Chen, P.-M., Wang, S.-L., Lu, T., & Shen, C.-C.
- Affiliations
- Tzu Chi University (TW)
- Kaohsiung Veterans General Hospital (TW)
- Taipei Veterans General Hospital (TW)
- National Central University (TW)
- Taichung Veterans General Hospital (TW)
- Central Taiwan University of Science and Technology (TW)
- National Chung Cheng University (TW)
- Corresponding author
- Shen, Cheng-Che
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-05-09
- Volume
- 9
- Issue
- 5
- Pages
- e97041
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4016227
- OpenAlex
- W2050230173
- Cited by
- 152
- References
- 40
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 10 · 2023: 15 · 2022: 16 · 2021: 19 · 2020: 14 · 2019: 16 · 2018: 13 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 1
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- polycystic ovary syndrome, psychiatric comorbidity, depressive disorders, anxiety disorders, sleep disorder, bipolar disorder, schizophrenia, women of reproductive age
- MeSH terms
- Adult, Mental Disorders, Female, Humans, Polycystic Ovary Syndrome, Regression Analysis, Retrospective Studies, Taiwan, Cohort Studies, Incidence, Proportional Hazards Models, Case-Control Studies, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.